The GMZ2 malaria vaccine: from concept to efficacy in humans

Introduction: GMZ2 is a recombinant protein consisting of conserved domains of GLURP and MSP3, two asexual blood-stage antigens of Plasmodium falciparum, and is designed with the aim of mimicking naturally acquired anti-malarial immunity. The rationale for combining these two antigens is based on a...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael Theisen (Author), Bright Adu (Author), Benjamin Mordmüller (Author), Subhash Singh (Author)
Format: Book
Published: Taylor & Francis Group, 2017-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!